25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism
Autor: | Romy Zemel, Assaf Issachar, Arie Erman, Noa Rapaport, Ran Tur-Kaspa, L. Bachmetov, Amiram Ravid |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
hepatitis C virus Hepacivirus medicine.disease_cause Calcitriol receptor lcsh:Chemistry chemistry.chemical_compound 0302 clinical medicine lcsh:QH301-705.5 Spectroscopy Cholecalciferol Reverse Transcriptase Polymerase Chain Reaction 25-hydroxyvitamin D3 Liver Neoplasms vitamin D3 General Medicine Computer Science Applications 030220 oncology & carcinogenesis medicine.drug Vitamin medicine.medical_specialty Carcinoma Hepatocellular Calcitriol Cell Survival Hepatitis C virus Real-Time Polymerase Chain Reaction Catalysis Virus Article Inorganic Chemistry 03 medical and health sciences Internal medicine Cell Line Tumor medicine Vitamin D and neurology Humans vitamin D receptor Physical and Theoretical Chemistry Mode of action Molecular Biology Calcifediol Organic Chemistry 030104 developmental biology Endocrinology chemistry lcsh:Biology (General) lcsh:QD1-999 Receptors Calcitriol CRISPR-Cas Systems |
Zdroj: | International Journal of Molecular Sciences, Vol 20, Iss 9, p 2367 (2019) International Journal of Molecular Sciences Volume 20 Issue 9 |
ISSN: | 1422-0067 |
Popis: | Previously, we have reported that the active vitamin D metabolite, calcitriol and vitamin D3 (cholecalciferol), both remarkably inhibit hepatitis C virus production. The mechanism by which vitamin D3 exerts its effect is puzzling due to the low levels of calcitriol produced in vitamin D3-treated Huh7.5 cells. In this study, we aimed to explore the mechanism of vitamin D3 anti-hepatitis C virus effect. We show that vitamin D3 activity is not mediated by its metabolic conversion to calcitriol, but may be due to its primary metabolic product 25(OH)D3. This is inferred from the findings that 25(OH)D3 could inhibit hepatitis C virus production in our system, and that adequate concentrations needed to exert this effect are produced in Huh7.5 cells treated with vitamin D3. Using the CRISPR-Cas9 editing technology to knockout the vitamin D receptor, we found that the antiviral activity of vitamin D3 and 25(OH)D3 was not impaired in the vitamin D receptor knockout cells. This result indicates that 25(OH)D3 anti-hepatitis C virus effect is exerted by a vitamin D receptor-independent mode of action. The possibility that vitamin D3 and 25(OH)D3, being 3&beta hydroxysteroids, affect hepatitis C virus production by direct inhibition of the Hedgehog pathway in a vitamin D receptor-independent manner was ruled out. Taken together, this study proposes a novel mode of action for the anti-hepatitis C virus activity of vitamin D3 that is mediated by 25(OH)D3 in a vitamin D receptor-independent mechanism. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |